Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2017-01-31

FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nitrostat (nitroglycerin) from Viatris Specialty LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrostat (Nitroglycerin)

Snippet

SUPPL AP for NITROSTAT (NITROGLYCERIN)